Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PENTIDS '800' vs AMCILL
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), transpeptidases that catalyze the final transpeptidation step of peptidoglycan cross-linking, leading to cell lysis.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Streptococcal infections (including Group A beta-hemolytic streptococci),Pneumococcal infections,Meningococcal infections,Syphilis,Lyme disease (early and late),Anthrax (treatment and prophylaxis),Actinomycosis,Clostridial infections (including tetanus and gas gangrene),Fusospirochetal infections (Vincent's angina),Rat-bite fever (Spirillum minus),Erysipeloid (Erysipelothrix rhusiopathiae),Listeriosis (Listeria monocytogenes),Pasteurella multocida infections,Diphtheria (as adjunctive therapy),Endocarditis prophylaxis (certain dental, oral, respiratory tract procedures)
Infections of the respiratory tract,Infections of the genitourinary tract,Meningitis,Septicemia,Endocarditis,Gastrointestinal infections,Prophylaxis of bacterial endocarditis
800 mg orally every 6 to 8 hours; maximum 4 g per day.
250-500 mg orally every 8 hours or 500 mg every 12 hours; for severe infections, up to 1 g every 6 hours intravenously.
0.5-1 hour; prolonged to 2-5 hours in renal impairment.
1-1.5 hours in normal renal function; prolonged to 7-10 hours in anuria.
Penicillin G is primarily metabolized in the liver via hydrolysis to penicilloic acid (inactive), with minor contributions from other pathways. Approximately 60-90% of an intravenous dose is excreted unchanged in the urine by tubular secretion; elimination half-life is 0.5-1 hour (prolonged in renal impairment).
Partially metabolized by hydrolysis; primarily excreted unchanged in urine via renal tubular secretion and glomerular filtration.
Renal: ~60-85% unchanged via glomerular filtration and tubular secretion; Biliary: ~10%; Fecal: <5%.
Renal: 60-80% unchanged; biliary: less than 10%; fecal: small amount.
~80% bound to serum albumin.
20% bound, primarily to albumin.
0.3-0.4 L/kg; low distribution, primarily extracellular fluid.
0.3 L/kg; indicates distribution into extracellular fluid.
Oral: 60-70% (reduced by food); IM: ~100%.
Oral: 50-70% (variable, reduced by food); IM: nearly 100%.
Cr Cl 30-50 m L/min: 800 mg every 8-12 hours; Cr Cl 10-29 m L/min: 800 mg every 12-24 hours; Cr Cl <10 m L/min: 800 mg every 24 hours.
For Cr Cl 30-50 m L/min: administer every 12 hours; for Cr Cl 10-29 m L/min: administer every 18-24 hours; for Cr Cl <10 m L/min: administer every 24 hours.
No specific adjustment required in mild to moderate hepatic impairment; contraindicated in severe hepatic impairment (Child-Pugh Class C). Caution in Child-Pugh Class B.
No specific adjustments recommended for Child-Pugh A or B; use caution in severe hepatic impairment (Child-Pugh C) with monitoring.
Children 2-12 years: 25-50 mg/kg/day divided every 6-8 hours; maximum 2 g per day. Infants and neonates: based on gestational and postnatal age, consult specific guidelines.
Children >1 month: 25-50 mg/kg/day orally divided every 8 hours; for severe infections, up to 100 mg/kg/day IV divided every 6 hours. Maximum dose: 2 g/day.
Use lowest effective dose; monitor renal function; increased risk of QT prolongation and Clostridioides difficile infection.
No specific dose adjustment required; monitor renal function and adjust based on creatinine clearance.
WARNING: SERIOUS HYPERSENSITIVITY REACTIONS, INCLUDING ANAPHYLAXIS, HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY. THESE REACTIONS ARE MORE LIKELY TO OCCUR IN INDIVIDUALS WITH A HISTORY OF PENICILLIN HYPERSENSITIVITY AND/OR A HISTORY OF SENSITIVITY TO MULTIPLE ALLERGENS. THERE HAVE BEEN REPORTS OF INDIVIDUALS WITH A HISTORY OF PENICILLIN HYPERSENSITIVITY WHO HAVE EXPERIENCED SEVERE HYPERSENSITIVITY REACTIONS WHEN TREATED WITH CEPHALOSPORINS. BEFORE INITIATING THERAPY WITH PENICILLIN, CAREFUL INQUIRY SHOULD BE MADE CONCERNING PREVIOUS HYPERSENSITIVITY REACTIONS TO PENICILLINS, CEPHALOSPORINS, OR OTHER ALLERGENS. IF AN ALLERGIC REACTION OCCURS, PENICILLIN SHOULD BE DISCONTINUED AND APPROPRIATE THERAPY INSTITUTED. SERIOUS ANAPHYLACTIC REACTIONS REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE. OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED.
No FDA black box warning.
Hypersensitivity reactions ranging from rash to anaphylaxis,Serious and occasionally fatal hypersensitivity reactions (including anaphylaxis) have been reported,Cross-sensitivity with cephalosporins and other beta-lactams,Clostridium difficile-associated diarrhea (CDAD) and pseudomembranous colitis,Overgrowth of non-susceptible organisms (including fungi) with prolonged use,Jarisch-Herxheimer reaction when treating syphilis or other spirochetal infections,Electrolyte disturbances with high doses (sodium content per million units: approximately 2.0 m Eq),Neurotoxicity (including seizures) with high doses or in patients with renal impairment,Hematologic adverse reactions (including positive Coombs test, hemolytic anemia, leukopenia, thrombocytopenia) with prolonged therapy,Interstitial nephritis,Use in patients with asthma or history of allergies requires caution
Hypersensitivity reactions including anaphylaxis,Clostridioides difficile-associated diarrhea,Superinfection,Risk of seizures with high doses or renal impairment,Use caution in patients with mononucleosis (high risk of rash)
History of hypersensitivity to any penicillin,History of immediate-type hypersensitivity reaction (e.g., anaphylaxis, urticaria) to cephalosporins or other beta-lactam antibiotics
Hypersensitivity to ampicillin, penicillins, or any component of the formulation,Infections caused by beta-lactamase-producing organisms
Absorption is significantly decreased by food; take at least 1 hour before meals or 2 hours after meals. Avoid acidic beverages (orange juice, tomato juice) as they may degrade the drug. No other significant food interactions.
Food does not significantly affect absorption; may be taken with or without meals. Avoid alcohol: may increase risk of disulfiram-like reaction (rare).
Pentids '800' contains penicillin G. Penicillin G is considered low risk in pregnancy. No increased risk of major congenital malformations has been observed with first trimester exposure. Second and third trimester use is safe when indicated. However, high doses near term may increase risk of neonatal hyperbilirubinemia and kernicterus due to competition for bilirubin binding sites.
FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. First trimester: Not associated with major birth defects. Second and third trimesters: Use only if clearly needed; potential for altered gut flora and diarrhea in neonate.
Penicillin G is excreted into breast milk in low concentrations (M/P ratio approximately 0.2). The amount ingested is unlikely to cause adverse effects in the nursing infant. However, there is potential for alteration of infant gut flora and allergic sensitization. Use with caution in breastfeeding women, especially in infants with history of penicillin allergy.
Ampicillin is excreted in breast milk in low concentrations (M/P ratio approximately 0.2). Compatible with breastfeeding; monitor infant for diarrhea or rash.
Pregnancy increases volume of distribution and renal clearance, potentially reducing serum concentrations. For serious infections (e.g., syphilis, group B streptococcus prophylaxis), standard doses may need to be increased or dosing interval shortened. Specific dose adjustments are not uniformly recommended; consider therapeutic drug monitoring if available. In severe cases, double dose or reduce interval from 6h to 4h may be considered.
Increased renal clearance during pregnancy may require higher doses to maintain therapeutic levels. Standard dosing is usually adequate for most indications; consider monitoring serum levels in severe infections.
PENTIDS '800' (Penicillin V Potassium) is a narrow-spectrum penicillin primarily used for streptococcal infections. For group A streptococcal pharyngitis, treat for 10 days to prevent rheumatic fever. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Renal dose adjustment required for Cr Cl <10 m L/min. First-line for pneumococcal infections but resistance is increasing.
AMCILL (ampicillin) is a broad-spectrum penicillinase-sensitive penicillin. Use caution in patients with renal impairment; dose adjustment required for Cr Cl <30 m L/min. Monitor for hypersensitivity reactions, especially in patients with cephalosporin allergy. IV administration may cause phlebitis; rotate infusion sites. Not effective against penicillinase-producing organisms including Staphylococcus aureus.
Take this medication exactly as prescribed, even if you feel better.,Take on an empty stomach with a full glass of water.,Complete the full course of therapy to prevent resistance.,Notify your doctor if you develop rash, itching, or difficulty breathing.,Inform your physician about all allergies, especially to penicillins or cephalosporins.,This medication may cause diarrhea; contact your doctor if severe or persistent.,Store at room temperature away from moisture and heat.,Do not share this medication with others.
Take exactly as prescribed; complete full course even if you feel better.,Notify your doctor if you develop rash, hives, or difficulty breathing.,May cause diarrhea; contact your doctor if severe or bloody.,Take with a full glass of water; avoid acidic beverages like orange juice.,Inform your doctor if you are pregnant, breastfeeding, or taking oral contraceptives (ampicillin may reduce efficacy).
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PENTIDS '800' vs AMCILL, answered by our medical review team.
PENTIDS '800' is a Penicillin Antibiotic that works by Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), transpeptidases that catalyze the final transpeptidation step of peptidoglycan cross-linking, leading to cell lysis.. AMCILL is a Penicillin Antibiotic that works by Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PENTIDS '800' and AMCILL depend on the specific clinical indication. These are both Penicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PENTIDS '800' is: 800 mg orally every 6 to 8 hours; maximum 4 g per day.. The standard adult dose of AMCILL is: 250-500 mg orally every 8 hours or 500 mg every 12 hours; for severe infections, up to 1 g every 6 hours intravenously.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PENTIDS '800' and AMCILL in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PENTIDS '800' is classified as Category C. Pentids '800' contains penicillin G. Penicillin G is considered low risk in pregnancy. No increased risk of major congenital malformations has been observed with first trimester ex. AMCILL is classified as Category C. FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. First trimester: Not associated with major birth defects. Second and third trimesters: Use only if clearl. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.